Finance

Beta
Lists
AARTIPHARM:NSE
Aarti Pharmalabs Ltd
₹647.00
-1.26%
(-8.25) 1D
May 29, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AARTIPHARM...
Open
₹656.25
High
₹663.00
Low
₹626.00
Mkt. cap
58.48B
Avg. vol.
204.77K
Volume
504.43K
Dividend
0.62%
Quarterly dividend
₹1.00
Ex-dividend date
Feb 16, 2026
P/E ratio
27.44
52-wk high
₹971.00
52-wk low
₹585.00
EPS
₹23.58
No. of employees
2K
Open
₹656.25
High
₹663.00
Low
₹626.00
Mkt. cap
58.48B
Avg. vol.
204.77K
Volume
504.43K
Dividend
0.62%
Quarterly dividend
₹1.00
Ex-dividend date
Feb 16, 2026
P/E ratio
27.44
52-wk high
₹971.00
52-wk low
₹585.00
EPS
₹23.58
No. of employees
2K
News stories
From sources across the web
About Aarti Pharmalabs Ltd
CEO-
Employees2.16K
Founded2019
Headquarters-
SectorPharmaceutical industry
Websiteaartipharmalabs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.86B
4.18B
4.32B
5.83B
Cost of goods sold
1.69B
2.10B
1.73B
2.83B
Cost of revenue
1.69B
2.10B
1.73B
2.83B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
412.57M
434.12M
433.78M
450.46M
Operating expense
1.44B
1.59B
1.86B
1.98B
Total operating expenses
3.14B
3.68B
3.59B
4.81B
Operating income
724.50M
499.50M
736.91M
1.02B
Other non operating income
15.96M
504.00K
-3.71M
80.52M
EBT including unusual items
654.55M
386.92M
628.69M
816.79M
EBT excluding unusual items
654.55M
386.92M
656.64M
816.79M
Income tax expense
159.53M
107.69M
149.13M
205.55M
Effective tax rate
24.37%
27.83%
23.72%
25.17%
Other operating expenses
802.86M
904.28M
1.14B
1.24B
Net income
495.01M
279.23M
479.56M
611.24M
Net profit margin
12.82%
6.67%
11.09%
10.49%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-67.95M
-106.65M
-125.80M
-168.63M
Net interest expenses
-67.95M
-106.65M
-125.80M
-168.63M
Depreciation and amortization charges
227.92M
247.69M
286.18M
281.56M
EBITDA
941.76M
737.30M
927.92M
1.21B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer